Global Plasma Protein Therapeutics Market Revenue to Touch US$31.84 bn by 2024

Drivers and trends such as these are studied in detail in a new report now available on the website of Market Research Reports Search Engine (MRRSE). The report, published by Market Research Reports Search Engine (MRRSE), is titled, “Plasma Protein Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024.” Plasma protein therapeutics are expected to constitute a market worth US$31.84 bn by 2024, exhibiting a 7.0% CAGR from 2016 through 2024.

Click to get Sample PDF: https://www.mrrse.com/sample/1857

The demand for plasma protein therapeutics is being driven considerably thanks to the use growing use of immunoglobulins in treating primary immunodeficiency diseases. The adoption of plasma protein therapeutics in the treatment of secondary immunodeficiency diseases has also augured well for the growth of the market. 

The report finds that the application of human albumins in treating burns, blood loss, and shock, has led to the emergence of new opportunities in the global plasma protein therapeutics market. At the same time, the emergence of new indications, the development of innovative solutions to safely collect high-quality plasma samples, and the launch of sophisticated plasma-derived therapies will strengthen the revenue potential of the global plasma protein therapeutics market. Adding to this is the fact that access to treatments and medicines has shown general improvements in developing countries, creating a wider scope for the use of plasma protein therapeutics as well.

Despite these positive trends and drivers, some risk factors will continue to act counter to the growth of the global plasma protein therapeutics market. The absence of well-defined reimbursement policies will likely deter patients from opting for plasma protein therapeutics. The many complexities and considerable monetary commitment associated with biologics manufacturing will also create an impediment for the growth of the global plasma protein therapeutics market. Yet, the overall increase in healthcare spending will also have a trickle-down effect on the plasma protein therapeutics market.

View Complete TOC with Tables and Figures at: https://www.mrrse.com/plasma-protein-therapeutics-market

The market for plasma protein therapeutics in North America is expected to contribute substantially to the global market in terms of revenue. In 2015, North America alone held a stake on over 40.7% of the market’s revenues. The most attractive regional market, however, is expected to be Asia Pacific. In other densely populated regions such as Latin America, the high-priced treatments and low diagnosis rates are acting as a challenge for the growth of the plasma protein therapeutics market.

In 2015, CSL Behring stood was the leader in the market with a revenue share of 30%. The other companies that held a significant share in the revenues of the global plasma protein therapeutics market in the same year were: Kamada, Biotest Pharmaceuticals, and Octapharma Inc.

About MRRSE

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords.

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street Suite 700
Albany, NY – 12207 (United States)
Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website: https://www.mrrse.com/

This release was published on openPR.